NexturnBioscience Co. Ltd Total Liabilities
NexturnBioscience Co. Ltd total liabilities. Based on the latest financial reports, NexturnBioscience Co. Ltd (089140) has total liabilities worth ₩128.65 Billion KRW (≈ $87.19 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 089140 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of NexturnBioscience Co. Ltd (2014–2024)
Total liabilities of NexturnBioscience Co. Ltd from 2014 to 2024. This chart illustrates how NexturnBioscience Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore NexturnBioscience Co. Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
NexturnBioscience Co. Ltd Competitors by Total Liabilities
The table below lists competitors of NexturnBioscience Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Digicontent Limited
NSE:DGCONTENT
|
India | Rs2.16 Billion |
|
Spirent Communications plc
LSE:SPT
|
UK | GBX199.60 Million |
|
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
|
USA | $770.00 |
|
EverGen Infrastructure Corp
V:EVGN
|
Canada | CA$30.69 Million |
|
GENENTA SCIENCE(SP.ADR)/1
F:K5F
|
Germany | €10.05 Million |
|
PROBIOTIX HEALTH LS-05
F:X90
|
Germany | €591.00K |
|
LBI Capital Bhd
KLSE:8494
|
Malaysia | RM52.70 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down NexturnBioscience Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 089140 total asset value.
Liquidity & Leverage Metrics
NexturnBioscience Co. Ltd Total Liabilities Ratios Explained
NexturnBioscience Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.84 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NexturnBioscience Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NexturnBioscience Co. Ltd (2014–2024)
The table below shows the annual total liabilities of NexturnBioscience Co. Ltd from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩96.41 Billion ≈ $65.34 Million |
-9.03% |
| 2023-12-31 | ₩105.98 Billion ≈ $71.82 Million |
+15.22% |
| 2022-12-31 | ₩91.98 Billion ≈ $62.34 Million |
+99.04% |
| 2021-12-31 | ₩46.21 Billion ≈ $31.32 Million |
+1689.03% |
| 2020-12-31 | ₩2.58 Billion ≈ $1.75 Million |
-48.45% |
| 2019-12-31 | ₩5.01 Billion ≈ $3.40 Million |
-72.17% |
| 2018-12-31 | ₩18.01 Billion ≈ $12.20 Million |
+502.69% |
| 2017-12-31 | ₩2.99 Billion ≈ $2.02 Million |
-65.43% |
| 2016-12-31 | ₩8.64 Billion ≈ $5.86 Million |
+172.72% |
| 2015-12-31 | ₩3.17 Billion ≈ $2.15 Million |
-28.10% |
| 2014-12-31 | ₩4.41 Billion ≈ $2.99 Million |
-- |
About NexturnBioscience Co. Ltd
Nexturn Co.,Ltd. develops and produces CNC automatic lathe machines in Korea and internationally. It provides CNC swiss-type automatic lathe products, high temperature display glass press equipment, and automatic line-up robots, as well as an intelligent intervention robot system based on robot 3D cardiovascular visualization technology. The company was formerly known as KMT Incorporated and chan… Read more